One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Journals package 3months
-
http://medilib.ir
- Duration of Time : 93 Day
Price : 100$- Special Price : 50$
Vascular biology and medicine: amyloid-beta alterations in neurocardiovascular diseases and new targets to treat smooth muscle cell dysfunction
doi : 10.1093/eurheartj/ehae878
Volume 46, Issue 3, 14 January 2025
Six years strong: the transformative journey of the European Society of Cardiology Patient Forum
A European network to develop virtual twin technology for personalized stroke management in atrial fibrillation: the TARGET consortium
European Research Council-funded grant: development of a novel cardiac tissue model
Non-bacterial thrombotic endocarditis: a clinical and pathophysiological reappraisal
Anthracycline-induced cardiovascular toxicity: validation of the Heart Failure Association and International Cardio-Oncology Society risk score
Navigating cardiotoxicity risk in cancer therapy: the importance of the HFA-ICOS score
Atheroma transcriptomics identifies ARNTL as a smooth muscle cell regulator and with clinical and genetic data improves risk stratification
Dissecting the effect of genetic variants on atherosclerosis: integrating bulk and single-cell transcriptomics
Elevated serum xylitol levels and cardiovascular risk: an active component or an innocent bystander?
Weekly Journal Scan: Do older patients with non-ST-segment elevation myocardial infarction receive any benefit from a routine invasive strategy?
Correction to: Anthracycline-induced cardiovascular toxicity: validation of the Heart Failure Association and International Cardio-Oncology Society risk score
Correction to: Routine application of cardiac magnetic resonance imaging in patients with suspected myocarditis from immune checkpoint inhibitor therapyÂ
